Peritoneal Mesothelioma Clinical Trials

More than 3,000 Americans are diagnosed with mesothelioma every year. This form of cancer occurs in those who have been exposed to asbestos. The prognosis is rarely favorable. Due to its long latency period, mesothelioma is difficult to diagnose and treat. Scientists and healthcare professionals are performing cancer research trials to find new treatments for this aggressive disease.

There have been over 175 clinical trials conducted in 2011. If you have been diagnosed with this rare form of cancer, ask your doctor about these research studies. Mesothelioma patients who participate in clinical trials have access to cutting edge therapies and new drugs there are not yet available to everyone.

Mesothelioma Treatment Options

Before participating in clinical trials, most people diagnosed with mesothelioma undergo standard treatments. Treatment options depend on the type of cancer cells, the location of the tumor, and the patient's age and general health. Doctors generally recommend surgery, radiation therapy, and chemotherapy. These three medical procedures are the accepted standard of treatment for mesothelioma. They can be used alone or together depending on the stage and extent of the cancer.

Surgical treatment aims to remove the tumor. This medical procedure is effective when the cancer is diagnosed in early stages. Chemotherapy kills cancer cells and shrinks the tumors. Radiation therapy is less aggressive than surgery and chemotherapy. This form of treatment reduces mesothelioma symptoms and alleviates pain.

What Is A Clinical Trial?

A clinical trial for mesothelioma ensures that new drugs and treatments can be tolerated and have measurable effects. Any new drug must be tested before the Federal Drug Administration (FDA) approves it for use in patients. These research studies carry potential benefits and risks. Clinical trials are usually conducted at large cancer research centers and use advanced treatment methods.

These studies have three phases. Phase I trials are conducted on 20 to 80 mesothelioma patients. They evaluate the drug's safety, dosage, and side effects. Phase II trials test 100 to 300 patients to analyze the treatment effectiveness. Phase III trials test up to 3,000 people to compare the effectiveness and side effects of the new drug against existing treatments.

Mesothelioma Clinical Trials

Some patients diagnosed with mesothelioma do not qualify for surgery or other standard treatment methods, but they may be eligible for clinical trials. Most research studies have pre-established eligibility requirements. Some of them require patients who have never undergone chemotherapy, while others require participants who have not been treated at all.

Clinical trials for mesothelioma explore more than just new medications. These research studies focus on new surgical procedures, medical testing techniques, screening methods, and even alternative therapies that could improve the patient's health and fight against the disease.

Your doctor is the only one who can help you decide whether to participate in a clinical trial or try standard treatments. Make sure you fully understand the risks associated with each procedure. For more information about mesothelioma clinical trials and treatment options, fill in the form below.